BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 26700076)

  • 1. Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre study.
    Miedema KG; Tissing WJ; Abbink FC; Ball LM; Michiels EM; van Vliet MJ; de Vries WY; Kamps WA; Norbruis OF; Fiocco M; de Groot-Kruseman HA; van de Wetering MD; de Bont ES
    Eur J Cancer; 2016 Jan; 53():16-24. PubMed ID: 26700076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
    Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
    J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study.
    Le Clech L; Talarmin JP; Couturier MA; Ianotto JC; Nicol C; Le Calloch R; Dos Santos S; Hutin P; Tandé D; Cogulet V; Berthou C; Guillerm G
    Infect Dis (Lond); 2018 Jul; 50(7):539-549. PubMed ID: 29451055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia.
    Bash RO; Katz JA; Cash JV; Buchanan GR
    Cancer; 1994 Jul; 74(1):189-96. PubMed ID: 8004575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
    Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
    Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
    N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
    Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early discharge of pediatric patients with cancer, fever, and neutropenia with low-risk of systemic infection.
    Gil-Veloz M; Pacheco-Rosas DO; Solórzano-Santos F; Villasís-Keever MA; Betanzos-Cabrera Y; Miranda-Novales G
    Bol Med Hosp Infant Mex; 2018; 75(6):352-357. PubMed ID: 30407457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
    Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
    Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
    Gupta A; Swaroop C; Agarwala S; Pandey RM; Bakhshi S
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):635-41. PubMed ID: 19684522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
    Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical analysis of combination therapy for febrile neutropenic patients in childhood cancer.
    Kobayashi S; Ito M; Sano H; Mochizuki K; Akaihata M; Waragai T; Hosoya M; Kikuta A
    Pediatr Int; 2013 Feb; 55(1):65-71. PubMed ID: 23240936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective audit of treatment of paediatric febrile neutropenia in Australasia.
    Chamberlain JD; Smibert E; Skeen J; Alvaro F
    J Paediatr Child Health; 2005 Nov; 41(11):598-603. PubMed ID: 16398846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department.
    Lynn JJ; Chen KF; Weng YM; Chiu TF
    Hematol Oncol; 2013 Dec; 31(4):189-96. PubMed ID: 23303687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fever and neutropenia in children with malignant disease.
    Roguin A; Kasis I; Ben-Arush MW; Sharon R; Berant M
    Pediatr Hematol Oncol; 1996; 13(6):503-10. PubMed ID: 8940733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
    Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia.
    Ponraj M; Dubashi B; Harish BH; Kayal S; Cyriac SL; Pattnaik J; Ranjith K; Pillai US; Jadhav N; Matta KK; Singh J; Jaffa E; Prakash B
    Support Care Cancer; 2018 Nov; 26(11):3899-3908. PubMed ID: 29774477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.